156 related articles for article (PubMed ID: 9692359)
21. Modifying normal tissue damage postirradiation. Report of a workshop sponsored by the Radiation Research Program, National Cancer Institute, Bethesda, Maryland, September 6-8, 2000.
Stone HB; McBride WH; Coleman CN
Radiat Res; 2002 Feb; 157(2):204-23. PubMed ID: 11835685
[TBL] [Abstract][Full Text] [Related]
22. Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.
Gorlick R; Anderson P; Andrulis I; Arndt C; Beardsley GP; Bernstein M; Bridge J; Cheung NK; Dome JS; Ebb D; Gardner T; Gebhardt M; Grier H; Hansen M; Healey J; Helman L; Hock J; Houghton J; Houghton P; Huvos A; Khanna C; Kieran M; Kleinerman E; Ladanyi M; Lau C; Malkin D; Marina N; Meltzer P; Meyers P; Schofield D; Schwartz C; Smith MA; Toretsky J; Tsokos M; Wexler L; Wigginton J; Withrow S; Schoenfeldt M; Anderson B
Clin Cancer Res; 2003 Nov; 9(15):5442-53. PubMed ID: 14654523
[TBL] [Abstract][Full Text] [Related]
23. Adverse event reporting and developments in radiation biology after normal tissue injury: International Atomic Energy Agency consultation.
Chen Y; Trotti A; Coleman CN; Machtay M; Mirimanoff RO; Hay J; O'brien PC; El-Gueddari B; Salvajoli JV; Jeremic B
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1442-51. PubMed ID: 16414207
[TBL] [Abstract][Full Text] [Related]
24. The Cure for Cancer: Not If but When.
Black KL
Oncologist; 1997; 2(5):IX-X. PubMed ID: 10388068
[TBL] [Abstract][Full Text] [Related]
25. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
26. Cell-cycle checkpoints and cancer.
Kastan MB; Bartek J
Nature; 2004 Nov; 432(7015):316-23. PubMed ID: 15549093
[TBL] [Abstract][Full Text] [Related]
27. Radiation-induced bystander effects. Mechanisms, biological implications, and current investigations at the Leipzig LIPSION facility.
Osterreicher J; Prise KM; Michael BD; Vogt J; Butz T; Tanner JM
Strahlenther Onkol; 2003 Feb; 179(2):69-77. PubMed ID: 12590316
[TBL] [Abstract][Full Text] [Related]
28. Molecular and translational radiation biology/oncology: what's up?
Rodemann HP; Wouters BG
Radiother Oncol; 2011 Jun; 99(3):257-61. PubMed ID: 21723635
[No Abstract] [Full Text] [Related]
29. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
30. Is translational research compatible with preclinical publication strategies?
Linder S; Shoshan MC
Radiat Oncol; 2006 Mar; 1():4. PubMed ID: 16722592
[TBL] [Abstract][Full Text] [Related]
31. Biologic basis for radiation oncology.
Coleman CN; Stevenson MA
Oncology (Williston Park); 1996 Mar; 10(3):399-411; discussion: 411-5. PubMed ID: 8820451
[TBL] [Abstract][Full Text] [Related]
32. Workshop on Fat and Cancer. Sponsored by the Diet, Nutrition and Cancer Program of the National Cancer Institute. Held at the National Institutes of Health, Bethesda, Maryland, December 10 - 12, 1979.
Cancer Res; 1981 Sep; 41(9 Pt 2):3677-826. PubMed ID: 7260923
[No Abstract] [Full Text] [Related]
33. [The Research Institute for Molecular Pathology (I.M.P.)--a new approach for cancer development].
Steinhardt M
Wien Klin Wochenschr; 1989 Dec; 101(23):795-8. PubMed ID: 2609663
[TBL] [Abstract][Full Text] [Related]
34. Conquering cancer through discovery research.
Cho WC
IUBMB Life; 2010 Sep; 62(9):655-9. PubMed ID: 20882644
[TBL] [Abstract][Full Text] [Related]
35. Current status and future potential of advanced technologies in radiation oncology. Part 1. Challenges and resources.
Vikram B; Coleman CN; Deye JA
Oncology (Williston Park); 2009 Mar; 23(3):279-83. PubMed ID: 19418829
[TBL] [Abstract][Full Text] [Related]
36. Technology for Innovation in Radiation Oncology.
Chetty IJ; Martel MK; Jaffray DA; Benedict SH; Hahn SM; Berbeco R; Deye J; Jeraj R; Kavanagh B; Krishnan S; Lee N; Low DA; Mankoff D; Marks LB; Ollendorf D; Paganetti H; Ross B; Siochi RA; Timmerman RD; Wong JW
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):485-92. PubMed ID: 26460989
[TBL] [Abstract][Full Text] [Related]
37. Beneficial liaisons: radiobiology meets cellular and molecular biology.
Coleman CN
Radiother Oncol; 1993 Jul; 28(1):1-15. PubMed ID: 8234865
[TBL] [Abstract][Full Text] [Related]
38. Smoking and occupation in epidemiologic studies. A workshop sponsored by the National Cancer Institute and the National Institute for Occupational Safety and Health. Bethesda, Maryland, December 15-16, 1986.
Am J Ind Med; 1988; 13(1):1-190. PubMed ID: 3344749
[No Abstract] [Full Text] [Related]
39. International Conference on Translational Research ICTR 2003 Conference Summary: marshalling resources in a complex time.
Coleman CN
Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):307-19. PubMed ID: 14751498
[TBL] [Abstract][Full Text] [Related]
40. The Future of Radiobiology.
Kirsch DG; Diehn M; Kesarwala AH; Maity A; Morgan MA; Schwarz JK; Bristow R; Demaria S; Eke I; Griffin RJ; Haas-Kogan D; Higgins GS; Kimmelman AC; Kimple RJ; Lombaert IM; Ma L; Marples B; Pajonk F; Park CC; Schaue D; Tran PT; Willers H; Wouters BG; Bernhard EJ
J Natl Cancer Inst; 2018 Apr; 110(4):329-340. PubMed ID: 29126306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
